期刊文献+

6例丙型肝炎病毒感染相关肝硬化患者脾切除后的抗病毒疗效 被引量:6

Clinical curative effect of antiviral therapy in 6 patients with HCV related cirrhosis after splenectomy
原文传递
导出
摘要 干扰素或干扰素联合利巴韦林是目前公认为抗HCV有效的治疗药物。但常规剂量的干扰素治疗常导致白细胞、血小板减少,而HCV相关肝硬化者血小板减少者更常见,由此妨碍了干扰素的抗病毒治疗。脾切除术、部分脾栓塞和促血小板生成素受体激动剂被证明是治疗血小板减少症有效的手段。
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2011年第12期932-933,共2页 Chinese Journal of Hepatology
基金 基金项目:上海市教育委员会重点学科(第五期)建设项目(J50307)
关键词 肝炎病毒 丙型 脾切除术 血小板减少 抗病毒治疗 Hepatitis C virus Splenectomy Thrombocytopenia Therapy, antiviral
  • 相关文献

参考文献8

  • 1Wenzel F, Gruber W, Giers G. Alteration of serum thrombopoietin levels in patients with chronic hepatitis C under interferon therapy. Clin Hemorheol Microcire, 2010, 44: 137-144.
  • 2Shigekawa Y, Uchiyama K, Takifuji K, et al. A laparoscopic splenectomy allows the induction of antiviral therapy for patients with cirrhosis associated with hepatitis C virus. Am Surg, 2011, 77: 174-179.
  • 3Hayashi H, Beppu T, Okabe K, et al. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol, 2010, 45: 554-559.
  • 4Ishikawa T, Ichida T, Sugahara S, et al. Thrombopoietin receptor (c-Mpl) is constitutively expressed on platelets of patients with liver cirrhosis, and correlates with its disease progression. Hepatol Res, 2002, 23: 115-121.
  • 5罗运权,张海阳,唐勋.应用解剖脾门法行原位脾切除的体会[J].中华肝胆外科杂志,2007,13(5):343-344. 被引量:7
  • 6Vecchio R, Cacciola E, Cacciola RR, et al. Portal vein thrombosis after laparoscopic and open splenectomy. J Laparoendosc Adv Surg Tech A, 2011, 21: 71-75.
  • 7Foruny JR, Blazquez J, Moreno A, et al. Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol, 2005, 17: 1157-1164.
  • 8Morihara D, Kobayashi M, Ikeda K. Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia. Hepatol Res, 2009, 39: 439-447.

二级参考文献2

共引文献6

同被引文献41

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:240
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3瞿全,江涛,姜洪池,夏穗生.论OPSI在脾外科中的重要性[J].中华肝胆外科杂志,2005,11(6):363-365. 被引量:11
  • 4苏海滨,王慧芬,林芳,许海苗,赵鸿,李雷,闫涛,牟劲松,李晨.肝衰竭合并细菌和真菌感染的回顾性研究[J].中华实验和临床病毒学杂志,2007,21(3):229-231. 被引量:11
  • 5中华医学会肝病学分会,中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华传染病杂志,2004,22(6):131-136.
  • 6Hatzakis A, Wait S, Bruix J, et al. The state of hepatitis B and C in Europe:report from the hepatitis B and C summit conference [J]. J Viral Hepat,2011,18 (Suppl 1) :1-16.
  • 7Colvin HM, Mitchell AE. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C [ M ], Washington, DC : National Academy Press ,2010.
  • 8Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses:a global overview[ J ]. Clin Liver Dis,2010,14 ( 1 ) : 1-21.
  • 9广东卫生厅.临床护理技术规范(基础篇)[M].广州:广东科技出版社,2007:118-123.
  • 10Dimarco V,Almasio PL,Ferraro D,et al.Peg-in-terferon alone or combinedwith ribavirin in HCV cirrhosiswith portalhypertension:a randomized controlled trial[J].Hepatology,2007,47(4):484-491.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部